Abb. 1 CheckMate-067: Wahrscheinlichkeit für Progressionsfreies Überleben (PFS) in der laufenden Überlebenszeitanalyse nach mindestens
18 Monaten (nach 2)
Derm_BMS I_EN_Fig1
This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.